Close Menu

NEW YORK (GenomeWeb) – Transgenomic announced today that it has sold its ion chromatography product line and all related assets to Edge BioSystems for roughly $2.1 million in cash.

Under the deal, Edge, which manufactures and distributes DNA sequencing sample preparation and clean-up products, acquired all of Transgenomics' ion chromatography products, licenses, technology, know-how, trademarks, and inventory.

Additional terms of the arrangement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bioethicists disagree with a research team's decision to allow the return of risk results for adult-onset conditions from a newborn sequencing project, according to Reuters.

Alterations to particular gene may enable the Quechua of Peru to better tolerate high-altitude life, Ars Technica reports.

Nature News reports that additional South Korean researchers have included the names of children on scientific papers when they did not contribute to the work.

In PLOS this week: statistical approach to prioritize rare variant searches, gene expression alterations in chronic obstructive pulmonary disease, and more.